Replay Click Here For Technical Support

Moderator: Gerald W. Parker, DVM, PhD, MS
Principal Deputy Assistant Secretary
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

THE FRENCH RNBC PROGRAM
Daniel Gillet, PhD
Coordinator for Biology for the French RNBC Program
Adjoint au Chef du Service d'Ingénierie Moléculaire des Protéines
Institut de Biologie et des Technologies de Saclay, Commissariat à l’Energie Atomique
Gif sur Yvette, France

THE UNITED KINGDOM'S HEALTH PROTECTION AGENCY (HPA)
RESEARCH AND DEVELOPMENT INITIATIVES
Miles Carroll, PhD
Deputy Director, Head of Research and Development
Centre for Emergency Preparedness and Response, Health Protection Agency
United Kingdom

GERMANY'S PRIORITY RESEARCH ISSUES
Gerd Sutter, DVM
Head, Department of Virology
Paul Ehrlich Institute
Langen, Germany

Walter Biederbick, PhD
Head, Federal Information Centre for Biological Safety
Robert Koch Institute
Berlin, Germany

THE CANADIAN CHEMICAL, BIOLOGICAL, RADIOLOGICAL-NUCLEAR, AND
EXPLOSIVES (CBRNE) RESEARCH AND TECHNOLOGY INITIATIVE (CRTI)
Mark A. Williamson, PhD
Deputy Director General, Defense Research and Development Canada (DRDC)
Centre for Security Science
Ottawa, Ontario, Canada

MEDICAL COUNTERMEASURE ENTERPRISE: INNOVATION FROM JAPAN
Tomohiko Makino, PhD
International Risk Management Coordinator
Office of Health Emergency Preparedness and Response, Health Science Division, Minister's Secretariat
Japanese Ministry of Health, Labour and Welfare
Tokyo, Japan

QUESTIONS FOR THE PANEL

Replay Click Here For Technical Support

Moderator and Speaker: Mary Kruger, MPP
Policy Director, Office of Policy, Strategic Planning and Communications
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

Daniel Dodgen, PhD
Director, Office of At-Risk Individuals, Behavioral Health, and Human Services Coordination
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

CDR Scott Santibañez, MD, MPHTM
Medical Officer and Senior Advisor for Vulnerable Populations, Influenza Coordination Unit
Coordinating Center for Infectious Diseases; Centers for Disease Control and Prevention
U.S. Department of Health and Human Services

Susan R. Cooper, MSN, RN
Commissioner
Tennessee Department of Health
Nashville, Tennessee

Kay Aaby, RN, MPH
Program Coordinator, Public Health Emergency Preparedness and Response
Montgomery County (Maryland) Department of Health and Human Services; Rockville, Maryland

Replay Click Here For Technical Support

Moderator: Jerome A. Donlon, MD, PhD
Chief Science Advisor
Office of Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

BIOMIMETIC IMMUNE MODELS FOR RAPID VACCINE ASSESSMENT
William Warren, PhD
Chief Executive Officer, VaxDesign Corporation
Orlando, Florida

DISSOLVABLE MICRONEEDLE DELIVERY SYSTEM
Sean Sullivan
Senior Graduate Researcher, School of Chemical and Biomolecular Engineering
Georgia Institute of Technology; Atlanta, Georgia

BREATH ANALYSIS TO DETECT RESPIRATORY DISEASE
Joany Jackman, PhD
Senior Scientist, Johns Hopkins Applied Physics Laboratory
Laurel, Maryland

TRANSLATION ENHANCING ELEMENTS IN
BIOPHARMACEUTICAL PRODUCTION CELL LINES
Vincent P. Mauro, PhD
Lead Scientist, Promosome LLC
Associate Professor, Department of Neurobiology, The Scripps Research Institute
La Jolla, California

SESSION A
Performance Measures for Medical Countermeasure
Distribution and Utilization in Public Health Emergency Response

SESSION B
Community Preparedness for All-Hazards Response:
Challenges for Planning

SESSION C
Building and Sustaining Medical Countermeasure Industries
for CBRN Threats and Pandemic Influenza

SESSION D
Novel Medical Countermeasure Forward Deployment and Dispensing Models:
Opportunities and Challenges

SEE YOU NEXT YEAR!

HHS PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE

2009 STAKEHOLDERS WORKSHOP & BARDA INDUSTRY DAY

To be held in the Washington, DC area SEPTEMBER 22 - 24, 2009
Subject to confirmation


Watch the BARDA Website for Location, Registration, and Abstract Submission Deadlines

WWW.HHS.GOV/ASPR/BARDA/